Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?

Transfusion

Volumn 53, Issue 2, 2013, Pages 373-381

  Fast, Loren D ^a   Nevola, Martha ^a   Tavares, Jennifer ^a   Reddy, Heather L ^a   Goodrich, Ray P ^a   Marschner, Susanne ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOFLAVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BLOOD; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; GAMMA IRRADIATION; HUMAN; HUMAN CELL; LEUKOCYTE; MOUSE; NONHUMAN; NORMAL HUMAN; PLASMA; T LYMPHOCYTE ACTIVATION; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; ULTRAVIOLET RADIATION; XENOGENEIC GRAFT VERSUS HOST DISEASE; XENOGRAFT;

ANIMALS; BLOOD; BLOOD TRANSFUSION; GAMMA RAYS; GRAFT VS HOST DISEASE; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HETEROLOGOUS; ULTRAVIOLET RAYS;

EID: 84873460097     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03715.x     Document Type: Article

References (26)

1. Blajchman MA,. Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse? Transfusion 1999; 39: 665-70.
2. Utter GH, Reed WF, Lee TH, Busch MP,. Transfusion-associated microchimerism. Vox Sang 2007; 93: 188-95.
3. Marschner S, Goodrich R,. Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfus Med Hemother 2011; 38: 8-18.
4. Marschner S, Fast LD, Baldwin Iii WM, Slichter SJ, Goodrich RP,. White blood cell inactivation after treatment with riboflavin and ultraviolet light. Transfusion 2010; 50: 2489-98.
5. Cancelas JA, Rugg N, Fletcher D, Pratt PG, Worsham DN, Dunn SK, Marschner S, Reddy HL, Goodrich RP,. In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood. Transfusion 2011; 51: 1460-8.
6. Tonnetti L, Thorp AM, Reddy H, Goodrich RP, Leiby DA,. Evaluation of babesia microti reduction with the Mirasol® System for whole blood. Transfusion 2010; 50s: 209A.
7. Goodrich RP, Doane S, Reddy HL,. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals 2010; 38: 20-30.
8. Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP,. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev 2008; 22: 133-53.
9. Fast LD, DiLeone G, Li J, Goodrich R,. Functional inactivation of white blood cells by Mirasol treatment. Transfusion 2006; 46: 642-8.
10. Fast LD, DiLeone G, Cardarelli G, Li J, Goodrich R,. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice. Transfusion 2006; 46: 1553-60.
11. King MA, Covassin L, Brehm MA, Racki W, Pearson T, Leif J, Laning J, Fodor W, Foreman O, Burzenski L, Chase TH, Gott B, Rossini AA, Bortell R, Shultz LD, Greiner DL,. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 2009; 157: 104-18.
12. Luban NL, Drothler D, Moroff G, Quinones R,. Irradiation of platelet components: inhibition of lymphocyte proliferation assessed by limiting-dilution analysis. Transfusion 2000; 40: 348-52.
13. Pelszynski MM, Moroff G, Luban NL, Taylor BJ, Quinones RR,. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood 1994; 83: 1683-9.
14. Mintz PD,. Cesium cessation? An advantage of pathogen reduction treatments. Transfusion 2011; 51: 1369-76.
15. van Hilten JA, Brand A,. Randomized clinical trials: the PREPAReS study. April 2011. [cited 2012 Apr 30]. Available from: URL: http://www.sanquin.nl/en/ research/research-program/research-departments/transfusion-medicine/ randomized-clinical-trials/
16. Asano H, Lee CY, Fox-Talbot K, Koh CM, Erdinc MM, Marschner S, Keil S, Goodrich RP, Baldwin WM III,. Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplantation 2007; 84: 1174-82.
17. Ohto H,. Gamma radiation does not prevent transfusion-induced HLA alloimmunization. Transfusion 1997; 37: 878-9.
18. Miura Y, Thoburn CJ, Bright EC, Chen W, Nakao S, Hess AD,. Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD. Blood 2002; 100: 2650-8.
19. Trandem K, Zhao J, Fleming E, Perlman S,. Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J Immunol 2011; 186: 3642-52.
20. Zhang N, Bevan MJ,. CD8(+) T cells: foot soldiers of the immune system. Immunity 2011; 35: 161-8.
21. Yamanaka N, Wong CJ, Gertsenstein M, Casper RF, Nagy A, Rogers IM,. Bone marrow transplantation Results in human donor blood cells acquiring and displaying mouse recipient class I MHC and CD45 antigens on their surface. PLoS ONE 2009; 4: e8489.
22. Ahmed KA, Xiang J,. Mechanisms of cellular communication through intercellular protein transfer. J Cell Mol Med 2011; 15: 1458-73.
23. Otani T, Toraya T, Sugimoto A, Okochi A, Suzuki M, Takeuchi M, Yamasaki F, Nakamura S, Kibata M,. Marked induction of CD4+CD8+ T cells with multifunctional properties by coculturing CD2+ cells with xenogeneic stromal cells. J Immunol Methods 2011; 372: 78-88.
24. Li S, Floess S, Hamann A, Gaudieri S, Lucas A, Hellard M, Roberts S, Paukovic G, Plebanski M, Loveland BE, Aitken C, Barry S, Schofield L, Gowans EJ,. Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection. PLoS Pathog 2009; 5: e1000707.
25. Akahoshi M, Takanashi M, Masuda M, Yamashita H, Hidano A, Hasegawa K, Kasajima T, Shimizu M, Motoji T, Oshimi K,. A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters. Transfusion 1992; 32: 169-72.
26. Hayashi H, Nishiuchi T, Tamura H, Takeda K,. Transfusion-associated graft versus-host disease caused by leukocyte-filtered stored blood. Anesthesiology 1992; 79: 1419-21.